Subscribe

Charles Bankhead

Authored Articles

Checkpoint Inhibition Consolidation Therapy Promising in High-Risk Hematologic Malignancies
Charles Bankhead
Lymphoma
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
First-Line Enasidenib Achieves Complete Remission in Older Patients with Acute Myeloid Leukemia and IDH2 Mutation
Charles Bankhead
Leukemia, Hematologic Malignancies
January/February 2019, Vol 10, No 1 | Payers’ Perspectives In Oncology: ASH 2018 Highlights
Read Article
New Clues to Mismatch Repair and PD-1/PD-L1 Status and Survival in Patients with Gastric or Esophageal Cancer
Charles Bankhead
Gastrointestinal Cancers
Web Exclusives
Read Article
High Response Rate with 3-Drug Combination for Untreated Follicular Lymphoma
Charles Bankhead
Lymphoma
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
New BTK Inhibitor Leads to Durable Responses in Relapsed or Refractory Chronic Lymphocytic Leukemia
Charles Bankhead
Leukemia, Hematologic Malignancies
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
Mogamulizumab, Anti-CCR4 Antibody, Improves Survival in Patients with Advanced Cutaneous T-Cell Lymphoma
Charles Bankhead
Emerging Therapies, Personalized Medicine
February 2018, Vol 9, No 1 | Payers' Perspectives In Oncology: ASH 2017 Highlights
Read Article
Clinical Pathways Help Integrate New Drugs, Reduce Variability in Care Delivery
Charles Bankhead
Clinical Pathways
December 2017, Vol 8, No 5
Read Article
Nivolumab Active in HPV-Positive Gynecologic Cancers
Charles Bankhead
Gynecologic Cancer
December 2017, Vol 8, No 5
Read Article
Higher Readmission Rates After Surgery Not Always Bad in Ovarian Cancer
Charles Bankhead
Gynecologic Cancer
June 2017, Vol 8, No 3
Read Article
Olaparib Maintenance Has Large Progression-Free Survival Advantage in Relapsed Ovarian Cancer with BRCA Mutation
Charles Bankhead
Gynecologic Cancer
June 2017, Vol 8, No 3
Read Article
New Vaccine Shows Monumental Survival Impact in Metastatic Cervical Cancer
Charles Bankhead
Gynecologic Cancer
June 2017, Vol 8, No 3
Read Article
Rubraca’s Benefit in Ovarian Cancer Hinges on Platinum Status, Previous Therapy
Charles Bankhead
Gynecologic Cancer
June 2017, Vol 8, No 3
Read Article
Impact of Elevated Tumor-Infiltrating Lymphocytes Differs Across Breast Cancer Subtypes
Charles Bankhead
Breast Cancer, Solid Tumors, Personalized Medicine
June 2017, Vol 8, No 3
Read Article
Immune Stimulant Fails Randomized Test in Platinum-Resistant Ovarian Cancer
Charles Bankhead
Immunotherapy, Personalized Medicine
June 2017, Vol 8, No 3
Read Article
Cabozantinib, a Multitargeted TKI, Active in Advanced Neuroendocrine Tumors
Charles Bankhead
Neuroendocrine Tumors
April 2017, Vol 8, No 2
Read Article
Long-Term Data Support Safety of Lanreotide in Advanced Neuroendocrine Tumors
Charles Bankhead
Neuroendocrine Tumors
April 2017, Vol 8, No 2
Read Article
Dual Anti-HER2 Therapy Boosts Progression-Free Survival in Advanced Breast Cancer
Charles Bankhead
Breast Cancer, Solid Tumors, Personalized Medicine
April 2017, Vol 8, No 2
Read Article
Hair Preservation Improved by 50% with Investigational Scalp-Cooling Device
Charles Bankhead
Breast Cancer, Solid Tumors, Personalized Medicine
April 2017, Vol 8, No 2
Read Article
Adding Everolimus to Antiestrogen Therapy Doubles Progression-Free Survival in Advanced Breast Cancer
Charles Bankhead
Breast Cancer, Solid Tumors, Personalized Medicine
April 2017, Vol 8, No 2
Read Article
HIV Drug Shows Promise in Refractory Multiple Myeloma
Charles Bankhead
Hematologic Malignancies, Multiple Myeloma
February 2017, Vol 8, No 1
Read Article
Ponatinib, a Tyrosine Kinase Inhibitor, Active in Patients with Relapsed or Refractory Chronic Myeloid Leukemia and BCR-ABL T315I Mutation
Charles Bankhead
Leukemia
February 2017, Vol 8, No 1
Read Article
Chemotherapy-Free Induction with Ibrutinib plus Rituximab Shows Unprecedented Efficacy in MCL
Charles Bankhead
Lymphoma
February 2017, Vol 8, No 1
Read Article
Cabozantinib a New First-Line Standard Therapy for High-Risk Advanced Renal-Cell Carcinoma?
Charles Bankhead
Renal-Cell Carcinoma
November 2016, Vol 7, No 10
Read Article
Adding Pembrolizumab to Chemotherapy as First-Line Treatment Significantly Improves Outcomes in Patients with Advanced NSCLC
Charles Bankhead
Lung Cancer, Solid Tumors
November 2016, Vol 7, No 10
Read Article
Immunotherapy with Atezolizumab Outperforms Chemotherapy in Previously Treated NSCLC
Charles Bankhead
Lung Cancer, Solid Tumors
November 2016, Vol 7, No 10
Read Article
Ceritinib, a Newer ALK Inhibitor, Improves Progression-Free Survival After Crizotinib Failure in NSCLC
Charles Bankhead
Lung Cancer, Solid Tumors
November 2016, Vol 7, No 10
Read Article
Angiogenesis Inhibitor Has Modest Effect on Progression-Free Survival in Metastatic Colorectal Cancer
Charles Bankhead
November 2016, Vol 7, No 10
Read Article
Fulvestrant Tops Anastrozole in ER-Positive Breast Cancer
Charles Bankhead
November 2016, Vol 7, No 10
Read Article
Adjuvant Ipilimumab Therapy Shows Long-Term Survival Benefit in Patients with High-Risk Melanoma
Charles Bankhead
ESMO 2016, ESMO
November 2016, Vol 7, No 10
Read Article
Immunotherapy Redefining the Treatment Strategy for Advanced Urothelial Cancer
Charles Bankhead
ESMO 2016, ESMO
November 2016, Vol 7, No 10
Read Article
Biology, Genetics Guide Diagnosis and Treatment of Thyroid Cancers
Charles Bankhead
Personalized Medicine, Thyroid Cancer
October 2016, Vol 7, No 9
Read Article
Value Assessments of Metastatic Colorectal Cancer Therapies Continue to Focus on Cost
Charles Bankhead
Value in Oncology
October 2016, Vol 7, No 9
Read Article
No Clear Selection Criteria for Genomic Testing in Patients with Metastatic Colorectal Cancer
Charles Bankhead
Colorectal Cancer, Solid Tumors
October 2016, Vol 7, No 9
Read Article
Many Cancer Survivors Have Untreated Depression
Charles Bankhead
Survivorship, Policies & Guidelines
October 2016, Vol 7, No 9
Read Article
New Genetic Test May Give Early Warning of Aggressive Prostate Cancers
Charles Bankhead
Genetic Testing, Personalized Medicine
October 2016, Vol 7, No 9
Read Article
Number of Cancers Convincingly Linked to Obesity More Than Doubles
Charles Bankhead
Cancer Prevention, Personalized Medicine
October 2016, Vol 7, No 9
Read Article
Nearly Half of Pancreatic Cancer Surgery Candidates Are Not Offered that Option
Charles Bankhead
Pancreatic Cancer, Solid Tumors
September 2016, Vol 7, No 8
Read Article
Changes in Patient-Reported Outcomes Linked to Better Survival in Metastatic Prostate Cancer
Charles Bankhead
Prostate Cancer, Solid Tumors
September 2016, Vol 7, No 8
Read Article
Rise in Metastatic Prostate Cancer Has Screening, Treatment Implications
Charles Bankhead
Prostate Cancer, Solid Tumors
September 2016, Vol 7, No 8
Read Article
ASCO Develops First-Ever Guidelines for Pain Management in Cancer Survivors
Charles Bankhead
Cancer Pain
September 2016, Vol 7, No 8
Read Article
Cologuard: Stool DNA Test Performs Well in Community-Based Setting Among Medicare Beneficiaries
Charles Bankhead
Colorectal Cancer, Solid Tumors
July 2016, Vol 7, No 6
Read Article
RAF Family Inhibitor Has Preliminary Activity in Multiple Tumor Types
Charles Bankhead
Clinical Trials
July 2016, Vol 7, No 6
Read Article
No Benefit from Nephrectomy in High-Risk Renal-Cell Carcinoma with Thrombus
Charles Bankhead
Genitourinary Cancers
July 2016, Vol 7, No 6
Read Article
Opioid Use Decreases in Gynecologic Cancer Surgery with Liposomal Bupivacaine
Charles Bankhead
Gynecologic Cancer
June 2016, Vol 7, No 5
Read Article
Slow Uptake of Minimally Invasive Surgery for Endometrial Cancer
Charles Bankhead
Gynecologic Cancer
June 2016, Vol 7, No 5
Read Article
Novel Regimen Outperforms Standard Chemotherapy in HER2 Breast Cancer
Charles Bankhead
Breast Cancer, Solid Tumors
June 2016, Vol 7, No 5
Read Article
Chemotherapy Use in Breast Cancer Declines with Gene-Based Assay
Charles Bankhead
Chemotherapy, Value in Oncology, Personalized Medicine
June 2016, Vol 7, No 5
Read Article
Mutation Testing Encouraged for All Patients with Ovarian Cancer
Charles Bankhead
Personalized Medicine
June 2016, Vol 7, No 5
Read Article
First-in-Class Stem-Cell Inhibitor Active in Pancreatic and Colorectal Cancers
Charles Bankhead
GI Cancers
May 2016, Vol 7, No 4
Read Article
Adjuvant Therapy at High-Volume Centers Improves Pancreatic Cancer Survival
Charles Bankhead
GI Cancers
April 2016, Vol 7, No 3
Read Article
Checkpoint Inhibitors Active in Gastric and Esophageal Cancers
Charles Bankhead
GI Cancers
April 2016, Vol 7, No 3
Read Article
Increased Physical Activity May Help Extend Survival After Prostate Cancer Diagnosis
Charles Bankhead
Prostate Cancer, Solid Tumors
March 2016, Vol 7, No 2
Read Article
Biomarker Panel May Aid Early Detection of Colorectal Cancer
Charles Bankhead
Colorectal Cancer, Personalized Medicine, Solid Tumors
March 2016, Vol 7, No 2
Read Article
Atezolizumab, a PD-L1 Inhibitor, Shows Impressive Results in Metastatic Urothelial Cancer
Charles Bankhead
Emerging Therapies, Personalized Medicine
March 2016, Vol 7, No 2
Read Article
Revised Survivorship Care Plan Template Reduces Time and Resource Commitments
Charles Bankhead
Survivorship, Policies & Guidelines
May 2015, Vol 6, No 4
Read Article
Value of MRI in Smoldering Myeloma Stressed by the International Myeloma Working Group
Charles Bankhead
Multiple Myeloma
May 2015, Vol 6, No 4
Read Article
Comprehensive Cancer Center Designation Trumps High Volume as Predictor for Outcomes in Ovarian Cancer
Charles Bankhead
Gynecologic Oncology Highlights
April 2015, Vol 6, No 3
Read Article
PARP Inhibitor Maintenance Too Pricey for Ovarian Cancer?
Charles Bankhead
Gynecologic Oncology Highlights
April 2015, Vol 6, No 3
Read Article
More Bad News for Erythropoiesis-Stimulating Agents in Chemotherapy-Induced Anemia
Charles Bankhead
Breast Cancer, Solid Tumors
March 2015, Vol 6, No 2
Read Article
Study Identifies Important Benefits of Cancer Survivorship Programs
Charles Bankhead
Breast Cancer, Solid Tumors
October 2014, Vol 5 , No 8
Read Article
Most Preoperative Breast MRIs Requested by Nononcologists
Charles Bankhead
Breast Cancer, Solid Tumors
October 2014, Vol 5 , No 8
Read Article
Mixed Results with Postprogression EGFR Inhibition in Advanced Non–Small-Cell Lung Cancer
Charles Bankhead
ESMO 2014 Highlights, ESMO
October 2014, Vol 5 , No 8
Read Article
New Data Show PFS, Survival Benefits with Bevacizumab in Breast Cancer
Charles Bankhead
ESMO 2014 Highlights, ESMO
October 2014, Vol 5 , No 8
Read Article
Cost Burden Follows Patients with Cancer into Survivorship
Charles Bankhead
Economics & Value, Economics of Cancer Care, Survivorship, Policies & Guidelines
September 2014, Vol 5, No 7
Read Article
Smoking Still a Major Cause of Cancer Death: A Call to Action on Tobacco Control
Charles Bankhead
Health Policy, Policies & Guidelines
June 2014, Vol 5, No 5
Read Article
Veliparib, a PARP Inhibitor, Active in Recurrent BRCA-Positive Ovarian Cancer
Charles Bankhead
Ovarian Cancer
June 2014, Vol 5, No 5
Read Article
Large Study Supports Regionalization of Gynecologic Cancer Care
Charles Bankhead
Society of Gynecologic Oncology
May 2014, Vol 5, No 4
Read Article
Preventive Oophorectomy May Not Eliminate Risk for BRCA1-Related Uterine Cancer
Charles Bankhead
Society of Gynecologic Oncology
May 2014, Vol 5, No 4
Read Article
Multitargeted Kinase Inhibitor Shows Promise for Breast Cancer Subgroup
Charles Bankhead
AACR Annual Meeting
May 2014, Vol 5, No 4
Read Article
Highest Response in Metastatic Renal-Cell Carcinoma with Pazopanib, Third-Line VEGF Inhibitor
Charles Bankhead
AACR Annual Meeting
May 2014, Vol 5, No 4
Read Article
CDK 4/6 Inhibitor Slows Progression of Metastatic Breast Cancer
Charles Bankhead
AACR Annual Meeting
May 2014, Vol 5, No 4
Read Article
Imaging Choice May Influence Brachytherapy Outcomes
Charles Bankhead
Personalized Medicine, Prostate Cancer, Solid Tumors
April 2014, Vol 5, No 3
Read Article
Promise of Personalized Care Hinges on Reimbursement Reform
Charles Bankhead
Economics & Value, Economics of Cancer Care
April 2014, Vol 5, No 3
Read Article
Previous Docetaxel Therapy Thwarts Enzalutamide Activity in CRPC
Charles Bankhead
Personalized Medicine, Prostate Cancer, Solid Tumors
March 2014, Vol 5, No 2
Read Article
Systemic Therapy Wins One, Loses One in Head and Neck Cancer
Charles Bankhead
Head and Neck Cancer
March 2014, Vol 5, No 2
Read Article
Outpatient Chemoradiation Regimen Matches Inpatient Care Outcomes, at Lower Costs
Charles Bankhead
Head and Neck Cancer
March 2014, Vol 5, No 2
Read Article
Virtual Patients Help Identify Opportunities for Cost-Savings
Charles Bankhead
Pathways, Policies & Guidelines
March 2014, Vol 5, No 2
Read Article
Second-Generation Genomic Sequencing Offers Opportunities, Poses Challenges
Charles Bankhead
Personalized Medicine
February 2014, Vol 5, No 1
Read Article
PIK3CA Mutation Thwarts Neoadjuvant Anti-HER2 Therapy in Breast Cancer
Charles Bankhead
Breast Cancer, Personalized Medicine
February 2014, Vol 5, No 1
Read Article
Aromatase Inhibitor–Related Pain Reduced with Exercise Regimen
Charles Bankhead
SABCS 2014
February 2014, Vol 5, No 1
Read Article
Sulfasalazine Fails to Prevent Radiotherapy-Induced Diarrhea
Charles Bankhead
Radiotherapy in Focus, Personalized Medicine
November 2013, Vol 4, No 9
Read Article
Expanded Radiotherapy Improves Breast Cancer Control
Charles Bankhead
Radiotherapy in Focus, Personalized Medicine
November 2013, Vol 4, No 9
Read Article
Oral VEGF Inhibitor, Cediranib, Improves Survival in Recurrent Ovarian Cancer
Charles Bankhead
Ovarian Cancer
November 2013, Vol 4, No 9
Read Article
PET Use for NSCLC Management Has Altered Resource Utilization, Increased Cost
Charles Bankhead
Economics & Value, Economics of Cancer Care
November 2013, Vol 4, No 9
Read Article
Cost-Effective Strategy for Early NSCLC Hinges on Operability of the Disease
Charles Bankhead
Economics & Value, Economics of Cancer Care
November 2013, Vol 4, No 9
Read Article
ASCO’s “Choosing Wisely” Top 5 List: Inappropriate Tests, Imaging, and Targeted Therapies
Charles Bankhead
ASCO Quality Care Symposium, ASCO
November 2013, Vol 4, No 9
Read Article
Development of Quality Measures Should Address Current Limitations
Charles Bankhead
ASCO Quality Care Symposium, ASCO
November 2013, Vol 4, No 9
Read Article
Integrating Patient-Reported Outcomes into Cancer Care
Charles Bankhead
ASCO Quality Care Symposium, ASCO
November 2013, Vol 4, No 9
Read Article
Need for Innovative Strategies for Quality Care Will Continue to Grow
Charles Bankhead
ASCO Quality Care Symposium, Quality Care, Policies & Guidelines, ASCO
November 2013, Vol 4, No 9
Read Article
IOM Cites Looming Cancer Care Crisis, Recommends Course-Correcting Strategies
Charles Bankhead
Economics & Value, Economics of Cancer Care
October 2013, Vol 4, No 8
Read Article
ASCO Adds Aromatase Inhibitor to Breast Cancer Prevention Options in Postmenopausal Women
Charles Bankhead
Breast Cancer, Personalized Medicine, Solid Tumors
September 2013, Vol 4, No 7
Read Article
Companion Diagnostics Information Not Easily Obtained
Charles Bankhead
Personalized Medicine
June 2013, Vol 4, No 5
Read Article
CHOP Disappearing as Standard of Care for Indolent NHL
Charles Bankhead
Hematologic Malignancies, Leukemia
May 2013, Vol 4, No 4
Read Article
No Loss of Efficacy with Anthracycline-Free Induction for Acute Lymphoblastic Leukemia
Charles Bankhead
Hematologic Malignancies, Leukemia
May 2013, Vol 4, No 4
Read Article
Liquid Biopsy Improves Detection of Secondary GIST Mutations Causing Drug Resistance
Charles Bankhead
Personalized Medicine
May 2013, Vol 4, No 4
Read Article
Gene Expression May Simplify Search for Effective Therapy in Head and Neck Cancer
Charles Bankhead
Head and Neck Cancer, Personalized Medicine
May 2013, Vol 4, No 4
Read Article
Tumor Subtype Fails to Explain Racial Disparity in Breast Cancer Survival
Charles Bankhead
Breast Cancer, Personalized Medicine, Solid Tumors
May 2013, Vol 4, No 4
Read Article
AUA Revises Its Guidelines for Prostate Cancer PSA Screening
Charles Bankhead
Prostate Cancer, Solid Tumors
May 2013, Vol 4, No 4
Read Article
Deviation from Clinical Guidelines Takes Toll on Ovarian Cancer Survival
Charles Bankhead
Ovarian Cancer, Personalized Medicine, Solid Tumors
May 2013, Vol 4, No 4
Read Article
Positron Emission Tomography Scanning May Identify Stage I NSCLC that Requires Chemotherapy
Charles Bankhead
AACR Annual Meeting
May 2013, Vol 4, No 4
Read Article
New Mantle-Cell Regimen Leads to “Remarkable” Response Rate
Charles Bankhead
AACR Annual Meeting
May 2013, Vol 4, No 4
Read Article
Neoadjuvant Chemotherapy Reduces Costs for Older Patients with Ovarian Cancer
Charles Bankhead
Economics & Value, Economics of Cancer Care
May 2013, Vol 4, No 4
Read Article
Palliative Care Cost-Effective for Platinum-Resistant Ovarian Cancer
Charles Bankhead
Economics & Value, Economics of Cancer Care, Palliative Care
May 2013, Vol 4, No 4
Read Article
Ibrutinib Shows Rapid, Dramatic Responses in Patients with CLL
Charles Bankhead
AACR Annual Meeting
May 2013, Vol 4, No 4
Read Article
Hypofractionation Validated for Breast Radiotherapy: Less Potential for Toxicity Shown
Charles Bankhead
Radiation Therapy, Personalized Medicine
March 2013, Highlights
Read Article
Intraoperative Radiotherapy Fares Well Against EBRT
Charles Bankhead
Radiation Therapy, Personalized Medicine
March 2013, Highlights
Read Article
Gene-Based Test Identifies Breast Cancer with Low Risk for Late Metastasis
Charles Bankhead
Prognostic Tests, Personalized Medicine
March 2013, Highlights
Read Article
Local Ablation Extends Therapy Duration for Patients with NSCLC, Improves Disease Control
Charles Bankhead
Lung Cancer
February 2013, Vol 4, No 2
Read Article
Preventive Therapy Preserves Sexual Function after Radiotherapy for Patients with Prostate Cancer
Charles Bankhead
Prostate Cancer
February 2013, Vol 4, No 2
Read Article
Infection Poses Lethal Risk Early in Patients with Multiple Myeloma
Charles Bankhead
ASH 2013 Annual Meeting
February 2013, Vol 4, No 2
Read Article
Chemotherapy-Free Regimen Tops Standard for Treating Patients with Acute Promyelocytic Leukemia
Charles Bankhead
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
“Dramatic” Responses with Targeted Agent for Patients with CLL
Charles Bankhead
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
More Evidence Supports the Anticancer Effect of Metformin
Charles Bankhead
Breast Cancer Symposium
October 2012, Vol 3, No 7
Read Article
Fewer Women Undergo Mammography since Recent Task Force Recommendations
Charles Bankhead
Breast Cancer Symposium
October 2012, Vol 3, No 7
Read Article
Benefit to Longer Chemotherapy in Metastatic Breast Cancer
Charles Bankhead
ESMO 2010 Conference, ESMO
November/December 2010, Vol 1, No 6
Read Article
Significant Impact for New Prostate Cancer Therapy
Charles Bankhead
ESMO 2010 Conference, ESMO
November/December 2010, Vol 1, No 6
Read Article

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.